Health Canada — Medical Devices · Canada · 2013-10-16 · Type III
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Archived by the issuing authority — kept for reference
Reported risk: Beckman Coulter has identified that the fluorescence photo-multiplier tube (PMT) gain settings displayed in the cytometer control dialog box may not reflect the actual PMTgain settings on the Navios flow cytometer. If a change to the fluorescence gain is made at any time to any protocol and saved (or not saved), all susequently loaded protocols will apply the previously set gain parameters regardless of what the cytometer control dialog is showing. Therefore, any subsequent protocol may not reflect the actual system gain in the cytometer control dialog box.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.